UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                   FORM 10-QSB

(Mark One)

[X]                           QUARTERLY REPORT PURSUANT TO
                             SECTION 13 OR 15(d) OF THE
                             SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: September 30, 2002
                                ------------------
Or

[  ]                          TRANSITION REPORT PURSUANT TO
                             SECTION 13 OR 15(d) OF THE
                             SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________ to _____________

Commission File Number: 000-33187

                    CareDecision Corporation
                    ------------------------
     (Exact name of registrant as specified in its charter)


             Nevada                                  91-2105842
             ------                                  ----------
 (State or other jurisdiction of        (I.R.S. Employer Identification No.)
 incorporation or organization)

 2 Penn Plaza, 15th Floor, Suite 1500-53, New York, NY      10121
 -----------------------------------------------------     --------
   (Address of principal executive offices)               (Zip Code)

                         (212) 292-4959
                         --------------
      (Registrant's telephone number, including area code)

 _______________________________________________________________
 (Former name, former address and former fiscal year, if changed
                       since last report)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
   the preceding 12 months (or for such shorter period that the registrant was
     required to file such reports), and (2) has been subject to such filing
                       requirements for the past 90 days.
                                 Yes [X] No [ ]

    APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE
                              PRECEDING FIVE YEARS:
    Indicate by check mark whether the registrant has filed all documents and
   reports required to be filed by Sections 12, 13 or 15(d) of the Securities
 Exchange Act of 1934 subsequent to the distribution of securities under a plan
                              confirmed by a court.
                                 Yes [ ] No [ ]

                      APPLICABLE ONLY TO CORPORATE ISSUERS:
The number of shares outstanding of each of the issuer's classes of common stock
               as of the most recent practicable date: 69,681,174


/1/

                            CareDecision Corporation
                        [formerly ATR Search Corporation]
                          (a Development Stage Company)


                                Table of Contents

                                                               Page

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

Consolidated Balance Sheet September 30, 2002 (unaudited)        4

Consolidated Statements of Operations For the Three Months       5
Ended September 30, 2002 and 2001 (unaudited) and For the
Nine Months Ended September 30, 2002 and 2001 (unaudited) and
For the Period July 6, 2000 (Inception) to September 30, 2002
(unaudited)

Consolidated Statements of Cash Flows For the Nine Months        6
Ended September 30, 2002 and 2001 (unaudited) and For the
Period July 6, 2000 (Inception) to September 30, 2002
(unaudited)

Notes to Financial Statements                                    7

Item 2. Management's Discussion and Plan of Operation           10

PART II - OTHER INFORMATION

Item 6. Exhibits                                                12

SIGNATURES                                                      13


/2/




                            CareDecision Corporation
                        [formerly ATR Search Corporation]
                          (a Development Stage Company)

                           Consolidated Balance Sheet
                                      as of
                         September 30, 2002 (unaudited)

                                       and

                      Consolidated Statements of Operations
                       for the Three and Nine Months Ended
                    September 30, 2002 and 2001 (unaudited),
                               and For the Period
           July 6, 2000 (Inception) to September 30, 2002 (unaudited)

                                       and

                      Consolidated Statements of Cash Flows
                            for the Nine Months Ended
                    September 30, 2002 and 2001 (unaudited),
                               and For the Period
           July 6, 2000 (Inception) to September 30, 2002 (unaudited)


/3/

                            CareDecision Corporation
                           [formerly ATR Search Corporation]
                          (a Development Stage Company)
                           Consolidated Balance Sheet
                                   (unaudited)



                                             September 30,
   Assets                                        2002
                                             -------------
   Current assets:
    Cash and equivalents                     $   349,807
    Notes receivable                              15,850
                                             -----------
     Total current assets                        365,657
                                             -----------

   Fixed assets, net                             256,393

   Intellectual property, net                  1,113,615
                                             -----------

                                             $ 1,735,665
                                             ===========

   Liabilities and Stockholders' Equity

   Current liabilities:
    Accounts payable                         $    10,000
    Notes payable                                485,418
                                             -----------
     Total current liabilities                   495,418
                                             -----------

   Stockholders' equity:
    Common stock, $0.001 par value;               69,681
     100,000,000 shares
     authorized, 69,681,174 shares issued
     and outstanding
    Additional paid-in capital                 2,696,498
    (Deficit) accumulated during
     development stage                        (1,525,932)
                                             -----------
                                               1,240,247
                                             -----------

                                             $ 1,735,665
                                             ===========




 The accompanying notes are an integral part of these financial statements.

/4/


                            CareDecision Corporation
                        [formerly ATR Search Corporation]
                          (a Development Stage Company)
                      Consolidated Statements of Operations
                                   (unaudited)
<TABLE>
<CAPTION>
                                   For the three          For the nine        July 6, 2000
                                    months ended          months ended       (inception) to
                                    September 30,         September 30,       September 30,
                                 2002        2001        2002         2001        2002
                              ----------  ----------  -----------  ----------  -----------
<S>                          <C>         <C>         <C>         <C>         <C>
Revenue                       $      500   $      -   $    1,555  $        -   $     1,555
                              ----------  ----------  -----------  ----------  -----------
Expenses:
 General & administrative        159,028          -       751,323       4,974      766,514
  expenses
 Consulting expense              276,056          -       276,056          -       601,056
 Depreciation                      1,363          -         2,756          -        71,756
                              ----------  ----------  -----------  ----------  -----------
   Total expenses                436,447          -     1,030,135       4,974    1,439,326
                              ----------  ----------  -----------  ----------  -----------

Other income (expense):
 (Loss) on debt settlement       (68,363)         -       (68,363)         -       (68,363)
 Interest income                   1,885          -         2,852          -         2,852
 Interest (expenses)             (14,399)         -       (22,650)         -       (22,650)
                              ----------  ----------  -----------  ----------  -----------

Net (loss)                    $ (516,824) $       -   $(1,116,741) $   (4,974) $(1,525,932)
                              ==========  ==========  ===========  ==========  ===========

Weighted average number of
 common shares outstanding -
 basic and fully diluted      21,027,802  16,100,000   33,279,930  16,100,000
                              ==========  ==========  ===========  ==========

Net (loss) per share - basic
and fully diluted             $    (0.02) $       -   $     (0.03) $    (0.00)
                              ==========  ==========  ===========  ==========
</TABLE>

    The accompanying notes are an integral part of these
                    financial statements.

/5/

                            CareDecision Corporation
                        [formerly ATR Search Corporation]
                          (a Development Stage Company)
                      Consolidated Statements of Cash Flows
                                   (unaudited)



                                                                   July 6, 2000
                                        For the nine months ended   (inception)
                                             September 30,              to
                                        -------------------------  September 30,
                                            2002          2001         2002
                                        ------------  -----------  ------------
Cash flows from operating activities
 Net (loss)                             $ (1,116,741) $         -  $ (1,525,932)
 Shares issued for services                  276,056            -       601,056
 Loss on debt settlement                      68,363            -        68,363
 Depreciation                                  2,756            -        71,756
 Adjustments to reconcile net
  (loss) to net cash (used) by
  operating activities:
   (Increase) in notes receivable            (15,850)           -       (15,850)
   Increase in accounts payable               10,000            -        10,000
                                        ------------  -----------  ------------
Net cash (used) by operating activities     (785,416)           -      (800,607)
                                        ------------  -----------  ------------


Cash flows from investing activities              -            -              -
                                        ------------  -----------  ------------

Cash flows from financing activities
 Increase in notes payable                   485,418            -       485,418
 Issuance of common stock                    649,801            -       664,996
                                        ------------  -----------  ------------
Net cash provided by financing
activities                                 1,135,219            -     1,150,414
                                        ------------  -----------  ------------

Net increase in cash                         349,803            -       349,807
 Cash - beginning                                  4            -             -
                                        ------------  -----------  ------------
 Cash - ending                          $    349,807  $         -  $    349,807
                                        ============  ===========  ============

Supplemental disclosures:
 Interest paid                          $          -  $         -  $          -
                                        ============  ===========  ============
 Income taxes paid                      $          -  $         -  $          -
                                        ============  ===========  ============

Non-cash transactions:
 Shares issued for services provided    $    276,056  $         -  $    601,056
                                        ============  ===========  ============



   The accompanying notes are an integral part of these financial statements.

/6/

                            CareDecision Corporation
                        [formerly ATR Search Corporation]
                          (a Development Stage Company)
                                      Notes

Note 1 - Basis of presentation

The  consolidated  interim financial statements included  herein,  presented  in
accordance  with  United  States generally accepted  accounting  principles  and
stated in US dollars, have been prepared by the Company, without audit, pursuant
to the rules and regulations of the Securities and Exchange Commission.  Certain
information  and footnote disclosures normally included in financial  statements
prepared  in accordance with generally accepted accounting principles have  been
condensed  or  omitted  pursuant  to such rules and  regulations,  although  the
Company  believes  that  the disclosures are adequate to  make  the  information
presented not misleading.

These  statements  reflect  all  adjustments,  consisting  of  normal  recurring
adjustments,  which,  in  the  opinion of management,  are  necessary  for  fair
presentation of the information contained therein.  It is suggested  that  these
consolidated  interim  financial statements be  read  in  conjunction  with  the
consolidated  financial statements of the Company for the period ended  December
31,  2001 and notes thereto included in the Company's Form 10-KSB.  The  Company
follows  the same accounting policies in the preparation of consolidated interim
reports.

Results  of  operations  for the interim periods are not  indicative  of  annual
results.

Note 2 - Going concern

The  accompanying  financial  statements have been prepared  assuming  that  the
Company  will continue as a going concern, which contemplates the recoverability
of  assets and the satisfaction of liabilities in the normal course of business.
As  noted  above, the Company is in the development stage and, accordingly,  has
not  yet  generated  a proven history of operations. Since  its  inception,  the
Company  has  been engaged substantially in financing activities and  developing
its  product  line, incurring substantial costs and expenses. As a  result,  the
Company  incurred  accumulated net losses from July 6, 2000 (inception)  through
the  period ended September 30, 2002 of $(1,525,932). In addition, the Company's
development  activities  since  inception have  been  financially  sustained  by
capital contributions.

The  ability of the Company to continue as a going concern is dependent upon its
ability  to  raise  additional  capital from  the  sale  of  common  stock  and,
ultimately,  the achievement of significant operating results. The  accompanying
financial  statements  do not include any adjustments  that  might  be  required
should  the Company be unable to recover the value of its assets or satisfy  its
liabilities.

Note 3 - Notes receivable

On  January 15, 2002, Medicius loaned an officer a total of $15,000 which is due
in  one  year at an interest rate of 8% per annum.  At the close of  the  merger
this note was assumed by the Company.

During the period ended June 30, 2002, the total interest income is $1,885.

Note 4 - Fixed assets

As  of  September  30, 2002, the Company received equipment  in  the  amount  of
$27,857 from Keith Berman, a beneficial owner of the Company.

As  of  September 30, 2002, the Company reclassified equipment in the amount  of
$229,899  from  Investment in Subsidiary pursuant to its merger  with  Medicius,
Inc.

Depreciation  expense totaled $2,756 for the nine-month period  ended  September
30, 2002.

/7/


                            CareDecision Corporation
                        [formerly ATR Search Corporation]
                          (a Development Stage Company)
                                      Notes

Note 5 - Intellectual property

During  the  period ended September 30, 2002, the Company acquired  Intellectual
Property  from  CareDecision.net, Inc, a private stockholder  owned  corporation
that completed several transactions the Company.  As a result of the merger  and
the   acquired   intellectual  property,  two  of  the  beneficial   owners   of
CareDecision.net  are now beneficial owners of the Company..   Pursuant  to  the
agreement,  the  Company paid CareDecision.net, Inc. the sum  of  $187,500  with
700,000  shares of the Company's $0.001 par value preferred stock.   During  the
three-months  ended  September 20, 2002, CareDecision.net,  Inc.  converted  its
preferred  stock into 1,725,000 shares of the Company's $0.001 par value  common
stock.

Note 6 - Investment in Care Technologies, LLC

On  June 21, 2001, the Company entered into an agreement with Care Technologies,
LLC whereby the Company sold all of the assets and liabilities of the Company in
exchange  for  a  10% ownership of Care Technologies, LLC.  The  investment  was
recorded  at  $229,899,  being the fair value of the  Company's  assets  on  the
acquisition date (see Note 4 above).

Note 7 - Notes payable

On  January  15,  2002,  the  Company received  $40,000  from  Keith  Berman,  a
beneficial  owner of the Company, which is due on December 31, 2003 and  accrued
interest  at 8% per annum.  The principal and accrued interest can be  converted
at  a rate of $0.10 per share.  During September 2002, Mr. Berman converted  his
$40,000  loan  plus interest into 1,267,963 shares of the Company's  $0.001  par
value common stock.

On  April  23,  2002, the Company received $475,000 from M and E  Equities,  LLC
which  is  due in two years at an interest rate of 9% per annum.  The  principal
and  interest  of  the note can be converted into five shares of  the  Company's
$0.001 par value common stock for each $1 of debt.  This note is secured by  all
the  assets  of  the  Company to include accounts receivable,  inventory,  fixed
assets, and intangible assets.

During the nine-months ended September 30, 2002, the Company recorded a total of
$62,573  from  various entities and individuals which is  due  upon  demand  and
accrued  interest  of  $1,715 at a rate of 8%.  During  the  three-months  ended
September  30, 2002, the note-holders converted their debt and accrued  interest
into 664,644 shares of the Company's $0.001 par value common stock

During  the nine-months ended September 30, 2002, the Company recorded  interest
expense of $22,650.

Note 8 - Stockholder's equity

During  the nine-months ended September 30, 2002, the Company issued a total  of
32,968,863  shares of its $0.001 par value common stock pursuant to its  reverse
merger  with  Medicius,  Inc. whereby each shareholder  received  three  Company
shares for every one Medicius, Inc. share held.

During  the  nine-months ended September 30, 2002, the Company issued  1,725,000
shares  of its $0.001 par value common stock to CareDecision.net, Inc.  pursuant
to  its  election  to convert 700,000 shares of the Company's $0.001  par  value
preferred stock into common stock.

During  the  nine-months ended September 30, 2002, the Company issued  6,927,737
shares of its $0.001 par value common stock to various persons and entities  and
to  note-holders  pursuant to their election to convert $64,288  in  convertible
debt inclusive of accrued interest.

During  the  nine-months ended September 30, 2002, the Company issued  6,340,000
shares  of its $0.001 par value common stock to various individuals and entities
for  consulting  services  valued at $276,056, the  fair  market  value  of  the
underlying shares on the date of issuance.

/8/


                            CareDecision Corporation
                        [formerly ATR Search Corporation]
                          (a Development Stage Company)
                                      Notes

During  the  nine-months ended September 30, 2002, the Company issued  2,539,574
shares of its $0.001 par value common stock for cash totaling $200,000.

There have been no other issuances of common stock.

Note 9 - Related party transactions

During the period ended September 30, 2002 the Company received equipment in the
amount of $27,857 from Keith Berman, a beneficial owner of the Company.

During  the  period ended September 30, 2002, the Company acquired  Intellectual
Property  from  CareDecision.net, Inc, a private stockholder  owned  corporation
that completed several transactions the Company.  As a result of the merger  and
the   acquired   intellectual  property,  two  of  the  beneficial   owners   of
CareDecision.net  are now beneficial owners of the Company..   Pursuant  to  the
agreement,  the  Company paid CareDecision.net, Inc. the sum  of  $187,500  with
700,000   shares   of   the   Company's  $0.001  par  value   preferred   stock.
CareDecision.net,  Inc.  then  elected to  convert  its  preferred  shares  into
5,075,000 shares of the Company's $0.001 par value common stock.

On  January  15,  2002,  the  Company received  $40,000  from  Keith  Berman,  a
beneficial  owner of the Company, which is due on December 31, 2003 and  accrued
interest at 8% per annum.  During the three-months ended September 30, 2002, Mr.
Berman elected to convert the note plus interest totaling $42,266 into 1,267,963
shares of the Company's $0.001 par value common stock.

Note 10 - Warrants

During  the  nine-months  ended  September 30,  2002,  the  Company  has  issued
5,540,795 Class A non-callable warrants to Medicius, Inc. shareholders  pursuant
to  the  merger  agreement (see Note 11 below).  Each Class A  warrant  unit  is
exercisable  into one share of the Company's $0.001 par value  common  stock  at
$0.04 per share plus 0.5 Class C warrants.  The Class A warrant units expire  on
June 30, 2005.

Note 11 - Reverse acquisitions agreement with Medicius, Inc. (MED)

On  June  21,  2001, the Company entered into an agreement with MED whereby  the
Company  acquired  all  of the issued and outstanding common  stock  of  NDI  in
exchange  for 38,043,863 voting shares of the Company's $0.001 par value  common
stock.   The  acquisition  was  accounted  for  using  the  purchase  method  of
accounting as applicable to reverse acquisitions because the former stockholders
of  the MED controlled the Company's common stock immediately upon conclusion of
the  transaction.   Under reverse acquisition accounting,  the  post-acquisition
entity  was accounted for as a recapitalization of MED.  The common stock issued
was  recorded  at  $0,  being  the fair value of the  Company's  assets  on  the
acquisition date.

The continuing company has retained December 31 as its fiscal year end.

/9/


              Item 2. Management's Discussion and Plan of Operation

Forward-Looking Statements

  This Quarterly Report contains forward-looking statements about our business,
financial condition and prospects that reflect our assumptions and beliefs based
on information currently available.  We can give no assurance that the
expectations indicated by such forward-looking statements will be realized.  If
any of our assumptions should prove incorrect, or if any of the risks and
uncertainties underlying such expectations should materialize, our actual
results may differ materially from those indicated by the forward-looking
statements.

  The key factors that are not within our control and that may have a direct
bearing on operating results include, but are not limited to, acceptance of our
services, our ability to expand our customer base, our ability to raise capital
in the future, the retention of key employees and changes in the regulation of
our industry.  There may be other risks and circumstances that we are unable to
predict.  When used in this Quarterly Report, words such as,  "believes,"
"expects,"  "intends,"  "plans,"  "anticipates,"  "estimates" and similar
expressions are intended to identify forward-looking statements, although there
may be certain forward-looking statements not accompanied by such expressions.
All forward-looking statements are intended to be covered by the safe harbor
created by Section 21E of the Securities Exchange Act of 1934.

General

  Our mission is to provide enhanced information technology (IT) to physicians
at the point of clinical decision.  Our software systems, communication tools
and suite of software applications obtained through our merger, permits a
physician to request critical patient medical and/or medication information via
the Web on a Microsoft Windows CE-based PDA at, or prior to the point-of-care.

  The system captures and displays the requested information, and overlays
formulaic medical treatment protocols and medical step therapies, creating not
only a patient specific historical medical chart, but also suggested treatment
alternatives, approved medications and diagnosis specific protocols.
Utilization of this system by the practicing physician enhances clinical
decision-making, improves physician productivity, insures formulary compliance,
reduces the cost of healthcare and positively impacts the care provided to the
patient.

  As of June 28, 2002, the Effective Date of our merger, the capital stock of
Medicius issued and outstanding immediately prior to the Effective Date was
converted into ATR Common Stock (prior to our name change to CareDecision
Corporation) as follows:

          (i)  Each share of Medicius Series A Preferred Stock was converted
into 3.5 common stock shares of ATR and .75 ATR common stock purchase Warrants.

          (ii) Each share of Medicius common stock was converted into 3.0 common
stock shares of ATR and .5 ATR common stock purchase Warrants.

          (iii)     After the Effective Date, all Medicius common stock purchase
warrants that remain unexercised as of the Effective Date and any Medicius
Convertible Notes that remain unconverted or unpaid on the Effective Date remain
exercisable for or convertible into the number of common stock shares of ATR
based on the same conversion ratio outlined in paragraph (ii) above.


/10/

Results of Operations

  We generated $1,555 in revenues for the nine-month period ended September 30,
2002.  Our future revenues will be reliant on the acceptance of our software
systems, communication tools and suite of software applications.

  Total operating expenses for the nine months ended September 30, 2002 were
$1,030,135 and $1,439,326 since inception.  Total operating expenses for the
nine-month period ended September 30, 2002 and since inception were entirely
related to general and administrative expenses, consulting fees, depreciation
and amortization, and organizational costs.

Future Business

  The elements of our future business strategy include: expanding
geographically into key markets through a combination of opening new offices and
developing relationships with clients to generate demand for our services;
recruiting qualified, medical software and other technical personnel to perform
technical, implementation and support duties as contracts are entered into,
although there can be no assurance that any such contracts will be secured; and
pursuing entry into new markets complementary to our proposed operations.
Future operations are dependent upon our ability to implement our business and
marketing strategies and to establish relationships and contracts with health
insurers and HMOs to provide our e-healthcare products and services.

  We have entered into a marketing agreement with Pharmacare, Inc., a wholly
owned subsidiary of CVS Corporation, and a provider of pharmacy benefit services
to health insurers.  Under this agreement, the Company plans to introduce the
Company's products to Pharmacare's client health insurers.

Liquidity and Capital Resources

  We believe our cash on hand of $349,807 will be sufficient to fund ongoing
fiscal 2002 and 2003 operations and provide for our working capital needs,
however, we have negative working capital of $129,761.  Our accountant has
issued a note concerning our ability to continue as a going concern.  As we are
still considered to be in the development stage, our prospects of continuing as
a going concern are contingent upon our ability to achieve and maintain
profitable operations.  Revenues generated over and above expenses will be used
for further development of our services, to provide financing for marketing and
promotion, to secure additional customers, equipment and personnel, and for
other working capital purposes.

  To date, we have financed our cash flow requirements through a public
issuance of common stock and through the issuance of notes.  During our normal
course of business, we will experience net negative cash flows from operations,
pending receipt of revenues.  Further, we may be required to obtain financing to
fund operations through additional common stock offerings and bank borrowings,
to the extent available, or to obtain additional financing to the extent
necessary to augment our available working capital.

  All investor inquiries should be directed via mail to Mr. Robert Cox,
President, CareDecision Corp.   2 Penn Plaza, 15th Floor, Suite 1500-53, New
York, New York 10121.

/11/

                           PART II - OTHER INFORMATION


     Item 6(a) - Exhibits



  Exhibit  Name and/or Identification of Exhibit
  Number

   3.1    Articles of Incorporation & By-Laws
                 (a) Articles of Incorporation of the Company
                 filed March 2, 2001.  Incorporated by
                 reference to the exhibits to the Company's
                 General Form For Registration Of Securities
                 Of Small Business Issuers on Form 10-SB,
                 previously filed with the Commission.

                 (b) Certificate of Amendment to the Articles
                 of Incorporation of the Company filed May 9,
                 2001.  Incorporated by reference to the
                 exhibits to the Company's General Form For
                 Registration Of Securities Of Small Business
                 Issuers on Form 10-SB, previously filed with
                 the Commission.

                 (c) Certificate of Amendment to the Articles
                 of Incorporation of the Company filed August
                 2, 2002.  Incorporated by reference to the
                 exhibits to the Company's June 30, 2002
                 Quarterly Report on Form 10-QSB, previously
                 filed with the Commission.

   3.2           By-Laws of the Company adopted March 16,
                 2001.  Incorporated by reference to the
                 exhibits to the Company's General Form For
                 Registration Of Securities Of Small Business
                 Issuers on Form 10-SB, previously filed with
                 the Commission.

   99.1          Certification under Section 906 of the
                 Sarbanes-Oxley Act (18 U.S.C. SECTION 1350)


     Item 6(b) - Reports Filed on Form 8-K

     For the quarter ended September 30, 2002 the Company did not file any
reports on Form 8-K with the Securities and Exchange Commission.


/12/


                                   SIGNATURES

Pursuant to the requirements of the Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.

                            CareDecision Corporation
-------------------------------------------------------------------------------
                                  (Registrant)




Date: November 8, 2002




By: /s/ Robert Cox
  _____________________________
  Robert Cox, President and CEO







Date: November 8, 2002




By: /s/ Michael Vogel
  ________________________________
  Michael Vogel, Treasurer and CFO


/13/